Keralty Hospital Miami | Keralty Research Center

Research site

Location

2500SW 75 Avenue, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

RDV

Palmitoylethanolamide

Niclosamide

TV-44749

Pomotrelvir

PEA

PBI-0451

APL-9

NP-120

Baricitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Maria T Bertoli

Verified by this site

Active trials

2 of 13 total trials

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON)

The purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other...

Active, not recruiting

COPD

COPD Exacerbation

Drug: Beclomethasone Dipropionate

Drug: Formoterol Fumarate

Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection (REVERSE2)

TP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinet...

Enrolling

Diabetic Foot Infection

Biological: TP-102

Other: Placebo